(Q35033838)

5 August 2017

title

A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

5 August 2017

main subject

0 references

tuberculosis

1 reference

inferred from title

multiple drug resistance

1 reference

1 reference

Diane J Ordway

3

0 references

Steven G Reed

12

object named as

Steven G Reed

1 reference

5 August 2017

11

Rhea N Coler

1 reference

5 August 2017

8

Ian M Orme

1 reference

5 August 2017

Sylvie Bertholet

1

1 reference

5 August 2017

Gregory C Ireton

2

1 reference

5 August 2017

Hillarie Plessner Windish

4

1 reference

5 August 2017

Samuel O Pine

5

1 reference

5 August 2017

Maria Kahn

6

1 reference

5 August 2017

Tony Phan

7

1 reference

5 August 2017

Thomas S Vedvick

9

1 reference

5 August 2017

Susan L Baldwin

10

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Science Translational Medicine

5 August 2017

published in

1 reference

5 August 2017

volume

2

1 reference

5 August 2017

issue

53

1 reference

5 August 2017

page(s)

53ra74

1 reference

Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Optimized subunit vaccine protects against experimental leishmaniasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Intradermal immunization improves protective efficacy of a novel TB vaccine candidate

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

The success and failure of BCG - implications for a novel tuberculosis vaccine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Immunology of tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Novel prophylactic and therapeutic vaccine against tuberculosis

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

A Toll-like receptor-2-directed fusion protein vaccine against tuberculosis

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110937

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis

25 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001094

Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001094

The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20944089

12 December 2020

inferred from PubMed ID database lookup

Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20944089

12 December 2020

inferred from PubMed ID database lookup

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20944089

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1126/SCITRANSLMED.3001094

1 reference

5 August 2017

1 reference

5 August 2017

1 reference